Cargando…
Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach
Multiple different recombinant and peptide antigens are now available for serodiagnosis of Lyme disease (LD), but optimizing test utilization remains challenging. Since 1995 the Centers for Disease Control and Prevention (CDC) has recommended a 2-tiered serologic approach consisting of a first-tier...
Autores principales: | Porwancher, Richard, Landsberg, Lisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428682/ https://www.ncbi.nlm.nih.gov/pubmed/34499659 http://dx.doi.org/10.1371/journal.pone.0253514 |
Ejemplares similares
-
Immunoblot Criteria for Diagnosis of Lyme Disease: A Comparison of CDC Criteria to Alternative Interpretive Approaches
por: Porwancher, Richard, et al.
Publicado: (2023) -
1760. Interferon Gamma Release Assay for Diagnosis of Lyme disease
por: Hefter, Yosefa, et al.
Publicado: (2018) -
ELISPOT assays and their diagnostic potential in Lyme disease and Lyme neuroborreliosis
por: Ettischer‐Schmid, N., et al.
Publicado: (2020) -
Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays
por: Henningsson, A. J., et al.
Publicado: (2013) -
The antibody response in Lyme disease.
por: Craft, J. E., et al.
Publicado: (1984)